GlaucomaCME
LECTURECME

Medical Glaucoma: Revelations in Treatment That Move Beyond Convention

Author(s)/Faculty: Thomas W. Samuelson, MD; Savak Teymoorian, MD, MBA
Release Date: 6/27/2018Expiration Date: 6/26/2019
Credit Type: CMENumber of Credits: 0.5
Content Type: LectureProvider:
Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Although promising advances in imaging have facilitated earlier glaucoma diagnosis, many patients with glaucoma remain at risk for disease progression due to insufficient control of intraocular pressure (IOP), which may be related to inadequacy of therapy options or lack of patient adherence to treatment regimens consisting of multiple therapies. Two new therapies, which differ in their mechanisms of action from currently available therapies, have been recently approved by the US Food and Drug Administration. In this CME activity, experts in the field will review and evaluate the latest clinical evidence for the safety and efficacy of current, new, and emerging classes of therapy. The mechanisms of action of the newest medications as well as clinical insights regarding the effective management of IOP and preventing vision loss will be discussed.